Offer - Urjas Oil for just ₹ 1 X
Ampirok Tablet DT is a prescription medicine that is available as a Tablet. Ampirok Tablet DT also has some secondary and off-label uses. These are listed below.
The right dosage of Ampirok Tablet DT depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
Apart from the aforementioned side effects, Ampirok Tablet DT can also lead to other problems, which have been listed below. These side effects of Ampirok Tablet DT are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Ampirok Tablet DT has a Safe effect for pregnant women and Safe effect on lactating mothers. It is important to know if Ampirok Tablet DT has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Ampirok Tablet DT related warnings section.
Individuals suffering from medical conditions like Kidney Disease, Kidney Disease, Jaundice must refrain from the use of Ampirok Tablet DT since this can cause severe adverse effects. Other contraindications of Ampirok Tablet DT have been discussed in the sections ahead.
Besides this, Ampirok Tablet DT may also have severe interaction with some medicines. A complete list of these interactions is given below.
You should also be aware that Ampirok Tablet DT is not safe while driving, and is not addiction.
Ampirok Tablet DT is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Based on research, the following side effects have been observed when Ampirok Tablet DT is used -
Moderate
Mild
Is the use of Ampirok Tablet DT safe for pregnant women?
Ampirok is safe for pregnant women.
Is the use of Ampirok Tablet DT safe during breastfeeding?
Ampirok does not show any harmful effects in lactating women.
What is the effect of Ampirok Tablet DT on the Kidneys?
Ampirok may have mild side effects on the kidneys.
What is the effect of Ampirok Tablet DT on the Liver?
There are no any side effects of Ampirok on the liver.
What is the effect of Ampirok Tablet DT on the Heart?
Ampirok is completely safe for the heart.
If you are suffering from any of the following diseases, you should not take Ampirok Tablet DT unless your doctor advises you to do so -
Is this Ampirok Tablet DT habit forming or addictive?
No, you will not get addicted to Ampirok Tablet DT.
Interaction between Food and Ampirok Tablet DT
Eating certain foods may increase the time it takes Ampirok Tablet DT to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Ampirok Tablet DT
No research has been done on this till date. Therefore, it is not known what the effect of taking Ampirok Tablet DT with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ampicillin
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 722-723
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 158-160
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; UNASYN® (ampicillin sodium/sulbactam sodium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 725
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 160-162